Should Smokeless, Spitless Tobacco Be SPITLESS..

September 24, 2007 - Should Smokeless, Spitless Tobacco Be SPITLESS.. - More and more studies are surfacing that indicate that users are at an increased risk of developing pancreatic cancer. (It should be remembered, as pointed out by Marita Broadstock in her systematic review (Systematic Review of the health effects of modified smokless tobacco products, NZHTA Report, February 2007, Volume 10 Number 1), the number of studies on smokeless tobacco is relatively slight compared to the wealth of literature published relating to smoking.) People who use Swedish moist snuff (snus) run twice the risk of developing cancer of the pancreas. This is the main result of a follow-up study conducted by Karolinska Institutet researchers amongst almost 300,000 male construction workers. The study is published online in the medical journal The Lancet (“Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung and pancreas in male construction workers; a retrospective cohort study”, Juhua Luo, Weimin Ye, Kazem Zendehdel, Johanna Adami, Hans-Olov Adami, Paolo Boffetto, Olof Nyrén.) As stated by Professor Olof Nyren, one of the authors of this paper, "We also have to be certain that an increase in snus marketing will not cause addictions in young people who otherwise wouldn’t have started to smoke." It's impossible to make sure this will not happen.. See related Newsbriefs:July 15, 2007 and June 20, 2007